Investor Presentaiton

Acute Therapies Chronic Therapies O Secondary Sales Performance Robust growth across all the major therapeutic segments in 9MFY22 Market rank 3 40.0% 41.5% 33.8% 25.9% 21.3% 24.4% 20.3% 19.0% Anti-infectives Gastro-intestinal Pain/ Analgesics Vitamins/Minerals / Nutrients Alkem sales growth YoY1,2 Indian pharma industry sales growth YoY1,2 +2 18 Market rank 29.6% 8.0% Anti-diabetic Alkem sales growth YoY1,2 8 27 27.7% 12.3% 12.0% 11.5% Neuro/ CNS Source: IQVIQ data 1 Domestic formulations sales; 2 For 9 months ended December 31, 2021 Cardiac Indian pharma industry sales growth YoY1,2 32.0% 18 Derma 12.1% O e ALKEM

View entire presentation